Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung

Lung Cancer

Volumn 75, Issue 1, 2012, Pages 58-65

  Miki, Makoto ^a,c   Ball, Douglas W ^b   Linnoila, R Ilona ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c Japanese Red Cross Sendai Hospital   (Japan)

Author keywords

Achaete scute homolog 1; Human; Lung carcinogenesis; Lung development; Neuroendocrine; Non small cell lung cancer; Small cell lung cancer; Synaptophysin

Indexed keywords

SYNAPTOPHYSIN; TRANSCRIPTION FACTOR MASH1;

ARTICLE; CARCINOID; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LUNG CANCER; NEUROEPITHELIUM; PRIMARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOID TUMOR; CARCINOMA, NEUROENDOCRINE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; NEUROENDOCRINE CELLS; RNA, MESSENGER; VESICULAR TRANSPORT PROTEINS;

EID: 83555165213     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.019     Document Type: Article

References (37)

1. Guillemot F., Lo L.C., Johnson J.E., Auerbach A., Anderson D.J., Joyner A.L. Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 1993, 75:463-476.
2. Johnson J.E., Birren S.J., Anderson D.J. Two rat homologues of Drosophila achaete-scute specifically expressed in neuronal precursors. Nature 1990, 346:858-861.
3. Kageyama R., Sasai Y., Akazawa C., Ishibashi M., Takebayashi K., Shimizu C., et al. Regulation of mammalian neural development by helix-loop-helix transcription factors. Crit Rev Neurobiol 1995, 9:177-188.
4. Nylen E.S., Becker K.L. The diffuse neuroendocrine system. Principles and practice of endocrinology and metabolism 2001, 1605-1611. Lippincott Williams and Wilkins, Philadelphia. K.L. Becker (Ed.).
5. Borges M., Linnoila R.I., van de Velde H.J.K., Chen H., Nelkin B.D., Mabry M., et al. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 1997, 386:852-855.
6. Huber K., Bruhl B., Guillemot F., Olson E.N., Ernsberger U., Unsicker K. Development of chromaffin cells depends on MASH1 function. Development 2002, 129:4729-4738.
7. Ito T., Udaka N., Yazawa T., Okudela K., Hayashi H., Sudo T., et al. Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development 2000, 127:3913-3921.
8. Kameda Y. Mash1 is required for glomus cell formation in the mouse carotid body. Dev Biol 2005, 283:128-139.
9. Lanigan T.M., DeRaad S.K., Russo A.F. Requirement of the MASH-1 transcription factor for neuroendocrine differentiation of thyroid C cells. J Neurobiol 1998, 34:126-134.
10. Sommer L., Shah N., Rao M., Anderson D.J. The cellular function of MASH1 in autonomic neurogenesis. Neuron 1995, 15:1245-1258.
11. Carney M.E., O'Reilly R.C., Sholevar B., Buiakova O.I., Lowry L.D., Keane W.M., et al. Expression of the human achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma). J Neurooncol 1995, 26:35-43.
12. Lo L.C., Johnson J.E., Wuenschell C.W., Saito T., Anderson D.J. Mammalian achaete-scute homolog 1 is transiently expressed by spatially restricted subsets of early neuroepithelial and neural crest cells. Genes Dev 1991, 5:1524-1537.
13. Porteus M.H., Bulfone A., Liu J.K., Puelles L., Lo L.C., Rubenstein J.L. DLX-2, MASH-1, and MAP-2 expression and bromodeoxyuridine incorporation define molecularly distinct cell populations in the embryonic mouse forebrain. J Neurosci 1994, 14:6370-6383.
14. Soderholm H., Ortoft E., Johansson I., Ljungberg J., Larsson C., Axelson H., et al. Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells. Biochem Biophys Res Commun 1999, 256:557-563.
15. Osada H., Tatematsu Y., Yatabe Y., Horio Y., Takahashi T. ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features. Cancer Res 2005, 65:10680-10685.
16. Linnoila R.I. Functional facets of the pulmonary neuroendocrine system. Lab Invest 2006, 86:425-444.
17. Phelps R.M., Johnson B.E., Ihde D.C., Gazdar A.F., Carbone D.P., McClintock P.R., et al. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem 1996, 24(Suppl.):32-91.
18. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993, 15:532-537.
19. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., et al. Laser capture microdissection. Science 1996, 274:998-1001.
20. Linnoila R.I., Mulshine J.L., Steinberg S.M., Funa K., Matthews M.J., Cotelingam J.D., et al. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol 1988, 90:641-652.
21. Jensen-Taubman S.M., Steinberg S.M., Linnoila R.I. Bronchiolization of the alveoli in lung cancer: pathology, patterns of differentiation and oncogene expression. Int J Cancer 1998, 75:489-496.
22. Linnoila R.I. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors. J Cell Biochem 1996, 24(Suppl.):92-106.
23. Linnoila R.I. Pulmonary endocrine cells in vivo and in vitro. Neuropeptides in respiratory medicine 1994, 197-224. Marcel Dekker, New York. M.A. Kaliner, P.J. Barnes, H.W. Kunz, J.N. Baraniuk (Eds.).
24. Reynolds S.D., Hong K.U., Giangreco A., Mango G.W., Guron C., Morimoto Y., et al. Conditional Clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1256-L1263.
25. Reynolds S.D., Giangreco A., Power J.H., Stripp B.R. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 2000, 156:269-278.
26. Linnoila R.I., Naizhen X., Meuwissen R., Berns A. Mouse lung neuroendocrine carcinomas: distinct morphologies, same transcription factors. Exp Lung Res 2005, 31:37-55.
27. Gazdar A.F., Carney D.N., Guccion J.G., Baylin S.B. Small cell carcinoma of the lung: cellular origin and relationship to other pulmonary tumors 1981, 145-175. Grune & Stratton, New York, London, Toronto, Sydney, San Francisco. F.A. Greco, R.K. Oldham, P.A. Bunn (Eds.).
28. Gosney J.R. Neuroendocrine cell populations in postnatal human lungs: minimal variation from childhood to old age. Anat Rec 1993, 236:177-180.
29. Jiang S.X., Kameya T., Asamura H., Umezawa A., Sato Y., Shinada J., et al. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol 2004, 17:222-229.
30. Westerman B.A., Neijenhuis S., Poutsma A., Steenbergen R.D., Breuer R.H., Egging M., et al. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Clin Cancer Res 2002, 8:1082-1086.
31. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001, 98:13790-13795.
32. Osada H., Takahashi T. Inclusion of the ASH1 gene that governs the neuroendocrine differentiation of lung epithelium as an additional prototypic 'lineage-survival oncogene'. Nat Rev Cancer 2007, (January). Online Source. 10.1038/nrc1947-c1.
33. Osada H., Tomida S., Yatabe Y., Tatematsu Y., Takeuchi T., Murakami H., et al. Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 2008, 68:1647-1655.
34. Jiang T., Collins B.J., Jin N., Watkins D.N., Brock M.V., Matsui W., et al. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res 2009, 69:845-854.
35. Linnoila R.I., Piantadosi S., Ruckdeschel J.C. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. Chest 1994, 106:367S-371S.
36. Schleusener J.T., Tazelaar H.D., Jung S.H., Cha S.S., Cera P.J., Myers J.L., et al. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer 1996, 77:1284-1291.
37. Shaw G.L., Gazdar A.F., Phelps R., Steinberg S.M., Linnoila R.I., Johnson B.E., et al. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem 1996, 24(Suppl.):173-185.